BioPharma Credit (LON:BPCR) Sets New 12-Month High – Time to Buy?

Shares of BioPharma Credit (LON:BPCRGet Free Report) hit a new 52-week high on Thursday . The stock traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.88 ($0.01), with a volume of 3483385 shares trading hands. The stock had previously closed at GBX 0.89 ($0.01).

BioPharma Credit Stock Performance

The firm has a market capitalization of £1.05 billion, a price-to-earnings ratio of 10.05 and a beta of 0.22. The stock’s fifty day moving average is GBX 0.86 and its two-hundred day moving average is GBX 0.87.

BioPharma Credit Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, March 13th. Stockholders of record on Thursday, February 6th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, February 6th. This represents a dividend yield of 3.4%. BioPharma Credit’s dividend payout ratio is presently 7,957.15%.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Featured Articles

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.